When Bowe Bergdahl got in the Way of DEA in Afghanistan

The secret story of how America lost the drug war with the Taliban

A high-stakes plan to indict Afghan drug lords and insurgency leaders on criminal conspiracy charges ran afoul of the Obama team. Five years later, it remains buried under Trump.

As Afghanistan edged ever closer to becoming a narco-state five years ago, a team of veteran U.S. officials in Kabul presented the Obama administration with a detailed plan to use U.S. courts to prosecute the Taliban commanders and allied drug lords who supplied more than 90 percent of the world’s heroin — including a growing amount fueling the nascent opioid crisis in the United States.

The plan, according to its authors, was both a way of halting the ruinous spread of narcotics around the world and a new — and urgent — approach to confronting ongoing frustrations with the Taliban, whose drug profits were financing the growing insurgency and killing American troops. But the Obama administration’s deputy chief of mission in Kabul, citing political concerns, ordered the plan to be shelved, according to a POLITICO investigation.

Now, its authors — Drug Enforcement Administration agents and Justice Department legal advisers at the time — are expressing anger over the decision, and hope that the Trump administration, which has followed a path similar to former President Barack Obama’s in Afghanistan, will eventually adopt the plan as part of its evolving strategy.

“This was the most effective and sustainable tool we had for disrupting and dismantling Afghan drug trafficking organizations and separating them from the Taliban,” said Michael Marsac, the main architect of the plan as the DEA’s regional director for South West Asia at the time. “But it lies dormant, buried in an obscure file room, all but forgotten.”

A senior Afghan security official, M. Ashraf Haidari, also expressed anger at the Obama administration when told about how the U.S. effort to indict Taliban narcotics kingpins was stopped dead in its tracks 16 months after it began.

“It brought us almost to the breaking point, put our elections into a time of crisis, and then our economy almost collapsed,” Haidari said of the drug money funding the Taliban. “If that [operation] had continued, we wouldn’t have had this massive increase in production and cultivation as we do now.”

An Afghan poppy farmer uses a blade to score the surface of a poppy in order to extract raw opium. | Getty Images A poppy farmer in Laghman Province scores a poppy to extract raw opium in April 2004. Afghan drug lords have pledged financial support to the Taliban in exchange for protection of their vast swaths of poppy and cannabis fields, drug processing labs and storage facilities. | Shah Marai/AFP/Getty Images

Poppy cultivation, heroin production, terrorist attacks and territory controlled by the Taliban are now at or near record highs. President Ashraf Ghani said recently that Afghanistan’s military — and the government itself — would be in danger of imminent collapse, perhaps within days, if U.S. assistance stops.

But while President Donald Trump has sharply criticized Obama’s approach in Afghanistan, his team is using a similar one, including a troop surge last year and possibly another, and, recently, a willingness to engage in peace talks with the Taliban.

The top-secret legal document that forms the plan’s foundation remains locked away in a vault at the U.S. Embassy in Kabul, and would need to be updated to reflect the significant expansion of the Taliban-led insurgency, said retired DEA agent John Seaman, who helped draft it as a senior law enforcement adviser for the Justice Department in Kabul. But he said the organizational structure of the Taliban leadership has remained mostly the same.

John Seaman
Retired DEA agent and Justice Department contractor in Kabul who distilled mountains of U.S. and Afghan evidence into a 940-page prosecution plan that detailed a decade-long complex conspiracy case against Taliban leaders and drug lords, traffickers, money launderers and other alleged associates.

“We have the ability to take these folks out,” he said. “Here’s your road map, guys. All you need to do is dust it off and it’s ready to go.”

The plan, code-named Operation Reciprocity, was modeled after a legal strategy that the Justice Department began using a decade earlier against the cocaine-funded leftist FARC guerrillas in Colombia, in concert with military and diplomatic efforts. The new operation’s goal was to haul 26 suspects from Afghanistan to the same New York courthouse where FARC leaders were prosecuted, turn them against each other and the broader insurgency, convict them on conspiracy charges and lock them away.

In Afghanistan, though, there was exponentially more at stake in what had become America’s longest war — and the clock was ticking.

By the time that plans for Operation Reciprocity reached fruition, in May 2013, the conflict had cost U.S. taxpayers at least $686 billion. More than 2,000 American soldiers had given their lives for it. And the Obama administration already had announced it would withdraw almost entirely by the following year. Like the Bush White House before it, it had concluded that neither its military force nor nuanced nation-building could uproot an insurgency that was financed by deeply entrenched criminal networks that also had corrupted the Afghan government to its core.

“We looked at this as the best, if not the only way, of preventing Afghanistan from becoming a narco-state,” said Seaman, referring to the government’s term for a country whose economy is dependent on the illegal drug trade. He described Operation Reciprocity as a fast, cost-effective and proven way of crippling the insurgency — akin to severing its head from its body — before the U.S. handed over operations to the Afghan government. “Without it,” he said, “they didn’t have a chance.”

A U.S soldier holds a machine gun in Afghanistan. A U.S soldier shows members of the Afghan media reconstruction projects in Panjshir Province, north of Kabul, in October 2007. The U.S. has spent billions of taxpayer dollars a year on its military campaign and reconstruction effort. But Congress earmarked just a tiny percentage of that spending for DEA efforts to counter the drug networks that bankroll the increasingly destructive attacks, records and interviews show. | Shah Marai/AFP/Getty Images

The document — a 240-page draft prosecution memo and 700 pages of supporting evidence — was the result of 10 years of DEA investigations done in conjunction with U.S. and allied military forces, working with embassy legal advisers from the departments of Justice and State. In May 2013, it was endorsed by the top Justice Department official in Kabul, who recommended it be sent to DOJ’s specialized Terrorism and International Narcotics unit in Manhattan. After agents flew in from Kabul for a three-hour briefing, the unit enthusiastically accepted the case and assigned one of its best and most experienced prosecutors to spearhead it.

The timeline

1970s and 1980s

Drug Enforcement Administration agents investigate Afghanistan’s narcotics trade but evacuate in 1979 when Soviet troops invade. Opium trafficking skyrockets with help from U.S.-funded Pakistani agents, who deliver weapons to Afghan mujahedeen freedom fighters and help them export their opium.

2002

The DEA leads Operation Containment, a coalition campaign launched after 9/11 to thwart the global narcotics trade by choking off the flow of heroin out of Afghanistan, the world’s leading opium producer, and helping the new Kabul government develop drug enforcement capability.

2005

The DEA takes custody of the first of several Taliban-affiliated Afghan heroin kingpins ultimately tried and convicted in New York courts of overseeing international trafficking organizations importing millions of dollars of narcotics into the U.S. since 1990. Baz Mohammad told co-conspirators that Islamic law approved of their “jihad” to take Americans’ money and kill them through heroin use and addiction.

2007

The DEA helps seize $3.5 billion in narcotics in Afghanistan, up from $1.6 billion in 2005, but the drug trade continues to fuel a massive expansion of the Taliban insurgency and governmentwide corruption. DEA agents double down on tactics they used against Colombia’s FARC narco-terrorists, including military style raids and targeting kingpins with U.S. indictments.

2009

Alarmed by Afghanistan’s inability, or unwillingness, to use its own courts to tackle drug kingpins, Congress funds the biggest-ever international surge of agents in DEA history. More than 80 agents ultimately deploy; three are killed in a November helicopter crash after a major drug raid.

2011

President Barack Obama announces a September 2014 U.S. troop withdrawal and end to the U.S. involvement in the conflict. DEA Kabul soon launches Operation Reciprocity in hopes of quickly decapitating the Taliban leadership before handing over operations to the Afghan government.

2013

DEA Kabul, with support from Justice and State department officials in Afghanistan, unveils a 940-page narcoterrorism prosecution plan to indict 26 Taliban commanders and allied drug lords and try them in U.S. courts. After DOJ’s Terrorism and International Narcotics Unit in New York approves it, a State Department diplomat in Kabul finds out and shuts down all investigative activity in the case.

2016

DEA agents bust a multimillion-dollar Afghanistan-to-U.S. heroin-smuggling ring that informants said had operated for decades. Presidential candidate Donald Trump vows to withdraw from Afghanistan but, once elected, says Taliban leaders and drug kingpins have fostered 20 terrorist groups in the country and threaten U.S. security.

2018

Senior Trump administration officials visit Afghanistan to discuss an additional troop surge and even peace talks with the Taliban but include no plans for incorporating DEA law enforcement efforts as part of their evolving Afghanistan strategy.

“These are the most worthy of targets to pursue,” Assistant U.S. Attorney Adam Fee, who had successfully prosecuted some of the FARC cases, wrote in an email to Seaman.

But before Fee could pack for his first trip to Afghanistan, Operation Reciprocity was shut down.

Its demise was not instantaneous. But the most significant blow, by far, came on May 27, 2013, when the then-deputy chief of mission, Ambassador Tina Kaidanow, summoned Marsac and two top embassy officials supporting the plan to her office, and issued an immediate stand-down order.

In an interview, Kaidanow — currently the State Department‘s principal deputy assistant secretary for political-military affairs — said she didn’t recall details of the meeting or the specifics of the plan. But she confirmed that she felt blindsided by such a politically sensitive and ambitious effort and the traction it had received at Justice. If she did issue such an order, she said, it was because she — as the administration’s “eyes” in Afghanistan — had concerns it would undermine the White House’s broader strategy in Afghanistan, including a drawdown that included the DEA as well as the military.

And the White House’s overriding priority ahead of the drawdown, she told POLITICO, was to use all tools at its disposal “to try and find a way to promote lasting stability in Afghanistan,” with peace talks integral to that effort. “So the bottom line is it had to be factored into whatever else was going on,” she said of the Taliban indictment plan. “We look at that entire array of considerations and think, you know, does it make sense in the moment? Does it make sense later on? Does it makes sense at all?”

Tina Kaidanow: State Department deputy chief of mission in Afghanistan who issued an immediate stand-down order halting Operation Reciprocity after discovering Justice Department prosecutors in New York had approved building a narcoterrorism criminal conspiracy case against Taliban leader Mullah Omar and 25 top associates.

Its authors counter that Operation Reciprocity was designed in accordance with that White House strategy, an assertion backed up by interviews with current and former officials familiar with it and a review of government documents and congressional records. The authors believe the real reason it was shut down was fears it would jeopardize the administration’s efforts to engage the Taliban in peace talks and still-secret prisoner swap negotiations involving U.S. Army Sgt. Bowe Bergdahl. They tried to revive the effort after Kaidanow transferred back to Washington that fall, but by then, they say, circumstances had changed and the project never gained traction again.

Recently, Seaman came forward to say that he and his former colleagues had all but given up on Operation Reciprocity until they discovered that the Trump administration had established a special task force to review and resurrect Hezbollah drug trafficking cases after a POLITICO report disclosed that they were derailed by the Obama administration’s determination to secure a nuclear deal with Iran.

The secret backstory of how Obama let Hezbollah off the hook

The Afghanistan team members said there are striking parallels between their case and Project Cassandra, the DEA code name for the Hezbollah investigations, as well as nuclear trafficking cases disclosed in another POLITICO report as being derailed because of the Iran deal. Taken together, they said, the cases show a troubling pattern of thwarting international law-enforcement efforts to the overall detriment of U.S. national security.

Now they are hoping the Trump administration will review and revive Operation Reciprocity, too, saying Trump’s Afghanistan strategy cannot succeed without also incorporating an international law enforcement effort targeting the drug trade that helps keep the Taliban in business.

Besides helping the military take strategic leaders off the battlefield, they said, it could provide much-needed leverage to finally bring the militant group to the negotiating table and also break up the criminal patronage networks undermining the Kabul government.

For now, though, the plan remains buried in DEA files, and even most agency leadership is unaware of it, several current and former agency officials said. “I don’t think a lot of people even know that we did this, that this plan is in existence and is a viable thing that can be resurrected and completed,” said Marsac, whose eight years in and around Afghanistan for the DEA make him one of the longest-serving Americans there during the war.

Michael Marsac Drug Enforcement Administration regional director in Kabul who launched Operation Reciprocity to combine 10 years of DEA investigations tying Taliban leaders directly to the global heroin trade into one unprecedented prosecution in U.S. courts before President Barack Obama withdrew American forces from Afghanistan.

Such an undertaking would involve serious logistical challenges to capture drug lords and prosecute them in the United States, not to mention the destabilizing effect on the Afghan economy, from farmers who grow poppies to corrupt government officials accustomed to bribes.

“We’ve made a deal with the devil on many occasions, in an effort not to antagonize anybody and kick the can down the road,” Marsac said. “But you’ve got to cut that off. It might be painful at first, but it has to be confronted.”

Haidari, the director-general of Policy and Strategy for Afghanistan’s Ministry of Foreign Affairs, agrees and says it is something his country cannot yet do entirely on its own. Haidari recently helped lead a summit meeting in Kabul of 23 countries, including the United States, in proposing another round of peace talks with the Taliban as well as more military aid. Last month, Afghanistan had its first official cease fire since the insurgency began, but it lasted only three days — and demands that the Taliban get out of the narcotics trafficking business weren’t among the conditions.

M. Ashraf Haidari Afghan counternarcotics official who lobbied Bush, Obama and Trump officials — mostly unsuccessfully — for more aggressive law enforcement efforts to take out drug kingpins and to stanch the flow of illicit narcotics proceeds that have fueled the Taliban insurgency and corrupted the Kabul government.

Haidari said the missing ingredient in the current scenario is a robust U.S. law enforcement effort to help Afghanistan starve the insurgency by attacking the Taliban’s drug funding, which, he noted, was precisely what Operation Reciprocity was designed to do.

“That much money automatically involves their leadership and shows that they are narco-terrorists. You have to go after them,” even if peace talks are also pursued, Haidari said. “If you want to make peace with them, and you discontinue going after them, then the DEA is no longer allowed to do what it needs to do. And that is exactly what happened.”

The alliance of the kingpins

Obama was upbeat in his June 2011 address announcing a gradual end to the U.S. war in Afghanistan, saying, ”We’re starting this drawdown from a position of strength.” The rugged country that once provided Al Qaeda its haven no longer represented the same terrorist threat to the American people, Obama said, and U.S. and coalition forces had thwarted the insurgency’s momentum.

The DEA’s Marsac believed from his many years in country that the situation on the ground wasn’t nearly as stable as Obama suggested. And that things were getting worse, not better.

Obama was correct that most of Al Qaeda’s remaining forces had left for neighboring Pakistan. But Taliban-controlled territory was now home to at least a dozen other terrorist groups with international aspirations. The Taliban itself had evolved, too, from an insular group without animus toward the United States into a lethal narco-terrorist army waging war against the American forces that had deposed it for its indirect role in the 9/11 attacks.

To finance its insurgency, the Taliban was reaping anywhere from $100 million to $350 million a year from its cut of the narcotics trade in hashish, opium, heroin and morphine, according to U.S., United Nations and other estimates. Much of the money went to pay for weapons, explosives, soldiers for hire and bribes to corrupt government officials.

For decades, much of the region’s narcotics trade had been controlled by the Quetta Alliance, a loose confederation of three powerful tribal clans living in the Pakistani border town of the same name. At a June 1998 summit, the clan leaders gathered secretly to approve another alliance — with the Taliban, which ruled Afghanistan at the time, according to classified U.S. intelligence cited in Operation Reciprocity legal documents.

Victims of violence are seen in Afghanistan.  CONTINUED VIOLENCE: A U.S. soldier and Afghan policemen (top) are seen through the broken window of a suicide bomber‘s car in Kabul in February 2013. Bottom left, an Afghan patient is wheeled on a trolley at Salang Hospital, north of Kabul, in September 2016. Bottom right, an Afghan amputee practices walking with her prosthetic leg at a Red Cross hospital in Kabul in April 2016. President Ashraf Ghani said recently that Afghanistan’s military — and the government — would be in danger of collapse, perhaps within days, if U.S. assistance stops. | Shah Marai/AFP/Getty Images

Under the “Sincere Agreement,” the drug lords pledged their financial support for the Taliban in exchange for protection of their vast swaths of poppy and cannabis fields, drug processing labs and storage facilities. The ties were solidified further when the U.S. invasion toppled the Taliban after 9/11 and forced top commanders to flee to Quetta, where they formed a shura, or leadership council.

In the early years of the U.S. occupation, the Pentagon and CIA cultivated influential Afghan tribal leaders who were not part of the Quetta Alliance, even if they were deeply involved in drug trafficking, in order to turn them against the Taliban. That willingness to overlook drug trafficking was assisted by their belief that the drugs were going almost entirely to Asia and Europe.

But a lot of Afghan heroin was also coming into the United States, indirectly, including through Canada and Mexico, according to DEA, Justice Department and congressional officials and documents. Over time, growing numbers of Americans addicted to legally prescribed opioids were finding an alternative in the ample, but often deadly, narcotics supply on the streets.

Even as the body counts mounted in Afghanistan, few Americans associated the war with growing opioid death and addiction rates in the U.S., including, importantly, appropriators in Congress. Lawmakers spent billions of taxpayer dollars annually on both the U.S. military campaign and reconstruction effort. But they earmarked just a tiny percentage of that for DEA efforts to counter the drug networks bankrolling the increasingly destructive attacks on both of them, records and interviews show.

As a result, as of 2003, the DEA deployed no more than 10 agents, two intelligence analysts and one support staff member in the entire country.

The agency’s primary mission was to disrupt and dismantle the most significant drug trafficking organizations posing a threat to the United States. Another mission was to train Afghan authorities in the nuts and bolts of counternarcotics work so that they could take on the drug networks themselves.

Over the next three years, as the U.S. military cut back its presence in Afghanistan to focus on the Iraq War, the Taliban roared back to life. The DEA agents and their Afghan protégés were left to stanch the flow of drug money to the growing insurgency.

Even after the U.S. and NATO countries began adding troops in 2006, the Afghan police and military counternarcotics forces were outgunned, outnumbered and outspent by the drug traffickers and their Taliban protectors, according to documents and interviews.

Kabul’s criminal justice system remained a work in progress. Afghan prosecutors, with help from the DEA and the Justice Department, were putting away 90 percent of those charged with narcotics crimes. But most were two-bit drug runners whose convictions didn’t disrupt the flow of drug money, records show.

Washington was coming to the realization that the Kabul government lacked the institutional capacity and the political will to take on the top drug lords, according to Rand Beers, who held a top anti-narcotics position in the George W. Bush administration.

Lucrative bribes had compromised police and government officials from the precinct level to the inner circle of U.S.-backed President Hamid Karzai. That meant the more senior that suspected drug traffickers were, the less successful U.S. authorities were in pressuring the Afghans to act against them.

As had been the case in Colombia, the drug kingpins were overseeing what had become vertically integrated international criminal conglomerates that generated billions of dollars in illicit annual proceeds. That made them, effectively, too big for their home government to confront.

The only criminal justice system willing and able to handle such networks was the one in the United States. By then, the U.S. Justice Department had indicted and prosecuted significant kingpins from Mexico, Thailand and, beginning in 2002, dozens of FARC commanders and drug lords from Colombia.

In response, the DEA took two pages from its “Plan Colombia” playbook. It began embedding specially trained and equipped drug agents in military units, to start developing cases against the heads of the trafficking networks. It also worked closely with specially vetted Afghan counternarcotics agents. These Afghans were chosen by DEA agents for their courage, experience and incorruptibility, and then polygraphed and monitored to keep them honest.

Together, the vetted Afghans and their DEA mentors established a countrywide network of informants and undercover operatives that penetrated deeply into the transnational syndicates. The crown jewel of that effort was a closely guarded electronic intercept program, in which DEA agents showed their Afghan counterparts how to obtain court-approved warrants and develop the technical skills needed to eavesdrop on communications.

The hundreds of warrants authorized by Afghan judges provided a real-time window into the flows of drugs and money — from negotiations of individual narcotic sales to forensic road maps of the trafficking networks’ logistics and financial infrastructure. DEA agents also worked with a special Sensitive Investigative Unit to map the drug, terror and corruption networks.

Afghan counternarcotic forces inspect sacks of opium.  Afghan counternarcotics forces inspect sacks containing opium after they were discovered in a fuel tanker traveling to Kabul in May 2005. Even after the U.S. and other NATO countries began adding troops in 2006, the Afghan police and military counternarcotics forces were outgunned, outnumbered and outspent by the drug traffickers and their Taliban protectors, according to documents and interviews. | Shah Marai/AFP/Getty Images

As the insurgency grew and became more costly to sustain, that evidence began to show the Taliban methodically assuming a more direct operational role in the drug trade, pushing out middlemen and extracting more profit — and money for the war effort — at every step of the process. All of the evidence was admissible in courts in Kabul and the United States. And it led agents straight to the top of the Taliban leadership — including its one-eyed supreme commander, Mullah Mohammad Omar, according to documents and interviews.

By the end of the Bush administration, the Justice Department had indicted four top Afghan drug lords, who were ultimately captured and flown stateside or lured there under pretense, then prosecuted and convicted. A top-secret “target list” circulating at the time drew a bull’s-eye on three dozen others who were next in the barrel, a Pentagon counternarcotics official said in an interview.

As Bush prepared to pass the reins of government to Obama, it was clear to both administrations that the Afghan government wouldn’t be able to halt the flow of drug money to the insurpgency on its own.

Bush’s outgoing Ambassador William Wood acknowledged as much in a withering cable back to Washington in January 2009, saying that the narcotics trade had become so pervasive that it made up one-third of Afghanistan’s gross domestic product, but “no major drug traffickers have been arrested and convicted [by local authorities] in Afghanistan since 2006.”

The battle against the Taliban would have to extend to courtrooms in the United States.

Launching ‘Plan Afghanistan’

The incoming Obama administration also publicly backed the “kingpin” strategy, as part of a counterinsurgency plan that focused on increased interdiction and rural development.

“Going after the big guys” was how Richard Holbrooke, Obama’s special representative for Afghanistan and Pakistan, described it to Congress.

That March, the DEA announced the most ambitious overseas deployment surge in its 40-year history — a six-fold increase of agents from 13 to 81.

Not everyone was an unflinching fan of the DEA’s approach. Many people in and out of the government feared that targeting those at the apex of the drug trade could backfire in a place like Afghanistan, where it often meant taking on tribal leaders with armies of fighters, tanks and even missiles at their disposal, recalled Kenneth Katzman, a senior analyst on Afghanistan issues for the Congressional Research Service, the independent research arm of Congress.

“These guys are powerful people,” Katzman told POLITICO. “Many have militias, and there are tribes, and subtribes, that depend on them for sustenance. You try to arrest someone like [that] and you are going to have a rebellion on your hands.”

But Haidari — then Afghanistan’s top national security diplomat in Washington — hailed the shift as being not only urgently needed but long overdue.

“A surge not only of military but law enforcement is exactly what we need,” said Haidari, who was then a senior official in the Karzai government. “It is something we have always demanded of the U.S. government.”

The DEA agents answering the call included a former Denver Broncos linebacker-turned-wiretapping expert and a former Marine with a Harvard Law degree. Several veteran commandos of the agency’s Latin American drug wars signed up too, including one storied agent who had built the case against the FARC.

“It was ‘Game on,’” Marsac said. “People wanted in on the fight. We were pulling them in from everywhere, and bringing them over in waves.”

After completing several months of special operations training, new agents hit the ground running, sweeping through fortified drug compounds as allied military forces provided cover fire. The agents seized and cataloged as evidence multi-ton caches of narcotics, as well as stockpiles of Taliban weapons found, increasingly, alongside them.

In November 2009, three DEA agents and seven American soldiers were killed when their helicopter crashed after a particularly intense drug raid in western Afghanistan. Obama and his attorney general, Eric Holder, traveled to Dover Air Force Base to receive their bodies.

For the tight-knit and fast-growing DEA team in country, the fight against the Taliban was, from that point on, an intensely personal one. So-called FAST teams — for foreign-deployed advisory support — brought Afghan drug agents to the front lines of the drug war, including Helmand Province, the epicenter of both the drug trade and the insurgency. U.S. and coalition military forces now embraced both the DEA agents and their Afghan trainees as full partners who were making significant inroads in attacking the increasingly intertwined drug-terror networks.

On June 22, 2011, Obama formally announced a September 2014 drawdown date for almost all U.S. troops and DEA agents. Marsac, the leader of all the DEA staff in the region, figured he had two years, at most, in which to marshal his agency’s newfound horsepower in ways that would make a lasting difference and give the Afghans a fighting chance on their own.

There wasn’t time to wrap up the myriad open investigations, even the multiyear ones targeting the kingpins. So Marsac proposed a legal Hail Mary of sorts: one giant U.S. conspiracy prosecution of the trafficking chieftains and the Taliban associates they financed.

In January 2012, he assembled a team to review the mountains of evidence in DEA vaults to see whether it supported such a prosecution.

Officials cut down poppies in Afghanistan. An Afghan government official (left) and two Afghan National Army soldiers cut down opium poppies in Bihsud District, north of Jalalabad, in April 2004. Afghan prosecutors, with help from the DEA and the Justice Department, were able to put away 90 percent of those charged with narcotics crimes. But most were two-bit drug runners whose convictions didn’t disrupt the flow of drug money, records show. | Shah Marai/AFP/Getty Images

The Justice Department had used such “wheel conspiracy” prosecutions for decades against international organized crime syndicates and drug cartels that had many tentacles. One especially potent advantage of such an approach was that evidence gathered against each defendant could be used to strengthen the overall conspiracy case against all of them.

The team concluded that the evidence didn’t support a conspiracy case centering on the fractious and fragmented trafficking networks. But Marsac believed it might support something even more audacious, which DEA and Justice had never done before: a conspiracy case combining major drug traffickers and terrorist leaders.

The Taliban senior leadership would be the hub in the center of the wheel, and its various trafficking partners, money launderers and the Quetta Shura the spokes arrayed around it. The main charge: That the Taliban had engaged in a complex conspiracy to advance the war effort through the production, processing and trafficking of drugs.

Marsac obtained approval from DEA’s Special Operations Division, a multi-agency nerve center that coordinates complex international law enforcement efforts. His deputy later did the same with DEA’s New York field office, which would be needed to help with support and logistics, such as safeguarding evidence and shepherding Afghan witnesses in country to testify before the grand jury hearing testimony in the case.

Marsac opened an official case file and, requiring a name, called it Operation Reciprocity. It would be DEA’s way of settling the score against the Taliban, he told the team, for its complicity in the 9/11 attacks and the deaths of the DEA’s own agents.

A tapestry of criminality

By the end of 2012, the team members were struggling to make progress on building the conspiracy case, given their crush of daily caseload demands. So Marsac asked the Justice Department attache in Kabul for reinforcements.

Specifically, Marsac wanted John Seaman, his old partner from their early days in Denver, who had become one of the DEA’s top experts in building conspiracy cases. After retiring in 2005 and doing some contract police work in Iraq, Seaman had spent the previous year on a Justice Department contract helping the Afghans identify sensitive anti-corruption and drug cases to pursue.

With time running out in Afghanistan, Marsac hoped Seaman could find a way to jump-start Operation Reciprocity. The Justice Department’s attache in Kabul, David Schwendiman, himself a veteran prosecutor of international war crimes tribunals, quickly approved the request.

David Schwendiman
Justice Department attache in Kabul who advised and supported Operation Reciprocity, fought unsuccessfully to save it and warned a DOJ lawyer in Washington that Kaidanow’s plan to dismantle DEA efforts in Afghanistan would leave “the Afghans blind” to the Taliban’s drug-fueled insurgency.

Marsac and Seaman believed the evidence for a Taliban-led conspiracy existed somewhere in the thousands of intercept recordings, cooperating witness statements, financial transaction records and everything else that DEA personnel had gathered, processed and filed away since first deploying in 2002. Seaman’s particular talent was in finding the puzzle pieces and understanding how they fit together.

Seaman, who was then 60 years old and a cancer survivor, scoured the evidence with focused intensity. Marsac would often leave work around 10 p.m., he said, “and I’d come back in the morning and John would still be still there.”

A few weeks later, Seaman quietly took Marsac aside and showed him a sheaf of papers summarizing evidence to build a prosecution against Taliban leaders and drug lords. “You’ve got it,” he said. “It’s there.”

Marsac and Seaman set up a war room within the DEA’s bunker near the Kabul airport, far from the U.S. Embassy. They papered the walls with photos of suspects, maps, charts and to-do lists.

One by one, Seaman constructed “target memos” for 26 key conspirators, each memo featuring 30 or so pages of alleged crimes committed, witnesses and evidence, along with, most importantly, a list of investigative avenues to pursue. Seaman then weaved all of it into the 240-page prosecution memo, an extraordinarily detailed tapestry of Afghanistan’s narcotics trade and the Taliban’s central — and financial — role in it from 1990 onward.

All the information in the memo was relayed to agents in the field, and to the legal advisers in Kabul. The team enlisted Ambassador Stephen McFarland, one of five State Department officials of ambassadorial rank in Afghanistan. McFarland’s special role was to oversee DEA and other law-enforcement programs.

Stephen McFarland
State Department ambassador overseeing law enforcement and “rule of law” programs in Afghanistan whose support of DEA counternarcotics investigations into politically sensitive targets — including Operation Reciprocity — prompted clashes with Kaidanow and his early and forced transfer back to Washington.

Schwendiman, the Justice attache, was encouraged. He sent for the FARC case files from Washington and determined that the Kabul investigators exceeded the standard of evidence used to indict and convict the Colombian guerrilla commanders in U.S. courts.

On his recommendation, the team sent the prosecution memo to the Justice Department’s Terrorism and International Narcotics unit in the Southern District of New York, which was known for taking on, and winning, the most ambitious and complex conspiracy cases.

Three Operation Reciprocity agents flew to Manhattan to brief the prosecutors, who quickly greenlighted taking the case. They spent three hours strategizing and discussing the monumental challenges inherent in building such a case, securing final DOJ headquarters approval and taking it to trial. The logistical hurdles would be predictable — and surmountable — but the political ones would not.

All agreed, however, that with Afghanistan descending into chaos, they had to try, according to Michael Schaefer, the supervisory DEA agent leading the investigation, and a second meeting participant.

El Chapo’s Rivals Extradited to US to be Witnesses

Primer: El Chapo complained repeatedly about his living conditions in prison while awaiting his case. So, a Brooklyn federal judge has ordered the Bureau of Prisons relax accommodations for notorious cartel leader Joaquín “El Chapo” Guzman–by giving him a glorified mail slot to pass documents with his attorneys.

Guzman can now enjoy a second, $1,000 screen and the slot during visits with his attorney Eduardo Balarezo, judge Brian Cogan ruled. The judge has yet to rule on the rest of a defense motion requesting the infamous inmate be allowed in-person visits with his legal team ahead of next April’s trial.

Cogan’s decision comes after Chief Magistrate Judge Roanne Mann visited the Metropolitan Detention Center to address the kingpin’s repeated assertions he was being held under the worst conditions possible. Mann recommended easing restrictions on Guzman as he languishes in jail.  According to an official of the U.S. Metropolitan Correctional Center in Manhattan where El Chapo is being held while awaiting trial, significant changes costing $150,000 would have to be made to an adjacent visiting room so that the kingpin can safely and securely meet with his attorneys to prepare for trial. He has plead innocent to 17 drug related charges.

Image result for new york metropolitan detention center

The special federal lock-up section where El Chapo is being held will have to undergo an 18-month “major demolition” and expensive wall restructuring along with relocating fire suppression systems and changing the floor layout according to an affidavit newly-filed by prosecutors. Government attorneys say the current MCC layout makes it impossible for Chapo to meet face-to-face with his team of defense attorneys because a rat’s nest of exposed electrical wires and piping might provide cover for the cartel boss to wage another escape attempt.

Image result for new york metropolitan detention center el chapo

Related reading: US prosecutors are reportedly considering charging ‘El Chapo’ Guzman with the killings of 6 US citizens and a DEA agent

Mexico has extradited the former right-hand man of “El Chapo” to face charges and serve as a key witness in the case against the former Sinaloa cartel boss.

Dámaso López, 52, was extradited Friday by authorities from the Mexican border city of Juárez. In a video posted to Twitter by the office of Mexico’s attorney general, a handcuffed López can be seen being led by armed police from a helicopter to an airplane for transfer to the U.S.

Arrested in 2017, Lopez—who has been dubbed the Graduate, due to his college education—is charged with drug trafficking and money laundering, among other crimes. In 2001, he is believed to have helped Joaquín “El Chapo” Guzmán, 61, the former kingpin of the Sinaloa cartel, escape from prison.

Guzmán was arrested again in 2014, but escaped from prison 18 months later in July 2015. After a massive manhunt, the drug baron was recaptured by Mexican authorities in January 2016. A year later, the cartel leader was extradited to the U.S., where he is currently awaiting trial.

Despite formerly serving under Guzmán, López aimed to take control of the Sinaloa cartel. He launched a bloody feud with El Chapo’s son for control in 2016. López allied with the Jalisco New Generation cartel and triggered a string of violence in the Mexican coastal states of Sinaloa and Baja California, The Guardian reported.

However, López was arrested in 2017, with his wing of the cartel in shambles. His own son, Dámaso López Serrano, had surrendered to U.S. authorities and pleaded guilty to charges of drug smuggling.

Mexico’s acting attorney general, Alberto Elias Beltran, said Friday that López is viewed as a key witness in the case against Guzmán. Beltran also said Mexico would suspend charges against López to avoid violating due process guarantees, according to Business Insider.

“He’s a key person as much as for the United States government as for the Mexican government,” Beltran told a local radio program. “We can bring to a good conclusion the process the United States is carrying out against Guzmán.”

The court case against El Chapo will begin in New York in September, according to Spanish newspaper El País. If he cooperates, López could testify in front of the court that Guzmán was the top leader of the Sinaloa drug organization. It is believed that López will for now be transferred to Virginia, where he will be held under tight security in the lead-up to the trial.

***

Here are a few people who will be sleeping a little easier tonight.

A Brooklyn federal judge ruled Friday that accused Mexican drug kingpin Joaquin “El Chapo” Guzman won’t be getting the names of the confidential informants who ratted him out.

The order from Judge Brian Cogan came after Guzman’s lawyers asked that prosecutors overseeing his upcoming drug-trafficking trial provide more than just summaries of the evidence they’ve collected.

Defense lawyer Eduardo Balarezo argued in a previously filed motion that the information they’ve been given is “utterly insufficient.”

“For example, the government’s disclosures merely state that it has ‘information,’ from some period of time long ago and describes the information in general terms. The government does not disclose the name(s) of the individual(s) that provided the information to the government,” the lawyer’s motion reads.

But Cogan on Friday sided with the government. Guzmán is expected to head to trial in September. He faces up to life behind bars on a rash of drug-trafficking charges.

Smart TV’s vs. Your Privacy

It is all getting quite tiresome.It is a cyber war you are in and you don’t know it.

There is Facebook sharing your data with foreign entities and governments. Then the NSA announced it was deleting 685 million personal records.

Then it was Siri and Alexa. Then we are told that Google is reading your GMail. And Google defends the practice.

Smart TVs are spying on you

If you watch television on an internet-connected TV, it may be watching you back.
Data-slurpers: The New York Times took a close look at the rise of services that track viewers’ watching habits—in particular Samba TV, which has claimed to gather second-by-second information from software on 13.5 million smart TVs in the US, this includes brand like smart TV Samsung, LG and Samba
Been here before: Last year, the Federal Trade Commission fined Vizio for $2.2 million over a similar issue. But that was because Vizio sold its data to third parties without users’ consent. Samba pays TV manufacturers like Sony and Philips to carry its software, but doesn’t sell its data. Instead, Samba uses it to sell targeted ads.
Why it matters: You may rip your TV’s plug out of the wall in horror. Or you may not care (Samba TV has said that 90 percent of users agree to turn the service on). Either way, this kind of thing could be going on in your living room—and the companies behind it aren’t exactly going out of their way to let you know about it.

What is a Smart TV?  photo

*** The New York Times was not the most recent reporting of this. In fact several media outlets sounded the alarm back in 2017.

The Federal Trade Commission said Monday that Vizio used 11 million televisions to spy on its customers. The television maker agreed to pay $2.2 million to settle a case with the FTC and the New Jersey attorney general’s office after the agencies accused it of secretly collecting — and selling — data about its customers’ locations, demographics and viewing habits.

With the advent of “smart” appliances, customers and consumer advocates have raised concerns about whether the devices could be sending sensitive information back to their manufacturers. The FTC says the Vizio case shows how a television or other appliance might be telling companies more than their owners are willing to share.

“Before a company pulls up a chair next to you and starts taking careful notes on everything you watch (and then shares it with its partners), it should ask if that’s O.K. with you,” Kevin Moriarty, an attorney with the FTC’s Division of Privacy and Identity Protection, wrote in a blog post. “Vizio wasn’t doing that, and the FTC stepped in.”

As part of the settlement, Vizio neither confirmed nor denied wrongdoing.

“Today, the FTC has made clear that all smart-TV makers should get people’s consent before collecting and sharing television viewing information, and Vizio now is leading the way,” Vizio’s general counsel, Jerry Huang, said of the settlement.

Although some consumers might not recognize the name Vizio, most have probably watched something on a Vizio television. The Irvine, Calif.-based firm, which Chinese firm LeEco recently announced it would buy, is the most popular TV maker in the United States. With 20 percent of the U.S. market, it made about 1 in 5 TVs sold here in 2016. LeEco has broad ambitions in the consumer space, with businesses that also produce a Netflix-style media service, smartphones and even cars.

According to the lawsuit, Vizio was literally watching its watchers — capturing “second-by-second information” about what people viewed on its smart TVs. That included data from cable, broadband, set-top boxes, over-the-air broadcasts, DVDs and streaming devices. Vizio also is accused of linking demographic information to the data and selling the data — including users’ sex, age and income — to companies that do targeted advertising.

Vizio said in its statement that it never paired viewing information with data that identified individual users but used viewing data only in “the ‘aggregate’ to create summary reports measuring viewing audiences or behaviors.”

The U.S. District Court for the District of New Jersey ordered Vizio to pay $1.5 million to the FTC and $1 million to the New Jersey attorney general’s office; Vizio won’t have to pay $300,000 of that unless it violates the order in the future.

The part of the settlement paid to the FTC reflects the amount that Vizio probably made from collecting and selling the customer information. Vizio will delete all the data it collected through the feature before March 2016. It must also prominently display its data collection and privacy policies to consumers and create a program to make sure its partners follow those policies.

Ridiculous Deductibles Broke the Healthcare System

Hello democrats….what again did Obamacare solve?

Sky-High Deductibles Broke the U.S. Health Insurance System

Employers are questioning a system they say costs patients too much.

Bloomberg: When Carla Jordan and her husband were hit with a cascade of serious medical issues, she knew that at least her family had health insurance through her job. What she didn’t realize was that even with that coverage, a constant stream of medical bills would soon push the family to the edge of financial collapse.

The Jordans, both 40, were once solidly in the middle class, but ever since the 2008 financial crisis, money has been tight at best. Then calamity hit. In 2016, Carla needed a gallbladder operation. Her husband John suffered a seizure the same year, followed by an unrelated infection that sent him to the emergency room. Toward the end of the year, Carla was diagnosed with diabetes. Even after paying $501 a month for medical insurance, they ended the year owing $8,000 to 18 different providers, with creditors threatening to garnish John’s wages.

Health plans similar to the Jordans’ that put patients on the hook for many thousands of dollars are widespread and growing, but some employers are beginning to have second thoughts. “Why did we design a health plan that has the ability to deliver a $1,000 surprise to employees?” Shawn Leavitt, a senior human resources executive at Comcast Corp., said at a conference in May. “That’s kind of stupid.” A handful of companies, including JPMorgan Chase & Co. and CVS Health Corp., have recently announced plans to reduce deductibles or cover more care before workers are exposed to the cost.

Yet it’s still the reality for a growing share of Americans. Today, 39 percent of large employers offer only high-deductible plans, up from 7 percent in 2009, according to a survey by the National Business Group on Health. Half of all workers now have health insurance with a deductible of at least $1,000 for an individual, up from 22 percent in 2009, according to data from the Kaiser Family Foundation. About 41 percent say they can’t pay a $400 emergency expense without borrowing or selling something, according to the Federal Reserve. The bottom line: People like the Jordans simply can’t afford to get sick.

Deductibles Keep Rising

About 40 percent of Americans can’t afford an unexpected $400 expense, according to the Federal Reserve.

***

The family had an Anthem Inc. insurance policy through Carla’s job as a public school teacher in Stafford County, Virginia. But the monthly premium barely covered any of their bills before paying a $2,000 deductible. And by the end of 2016, the Jordans were deep in the hole to doctors, hospitals, an anesthesiologist, urgent care, and various labs and testing centers. Their doctors sent collections notices. Some dropped them as patients until they paid up.

“I actually dreaded going to the mailbox,” Carla recalled. “I feel like I’ve done everything I’m supposed to do.” And yet, she said, sickness pushed the family “right over the brink.”

Related reading: Five Questions About Amazon’s Play for the $300 Billion Pharmacy Market

Since the early 2000s, employers have mostly embraced high-deductible health plans. The thinking has been that requiring workers to shoulder more of the cost of care will also encourage them to cut back on unnecessary spending. But it didn’t work out that way. In the wake of the 2008 financial crisis, many families were hard-pressed to meet their soaring health-insurance deductibles. At the same time, studies show that many put off routine care or skipped medication to save money. That can mean illnesses that might have been caught early can go undiagnosed, becoming potentially life-threatening and enormously costly for the medical system.

Patients Exposed

The share of Americans under 65 enrolled in high deductible plans is rising

The family had an Anthem Inc. insurance policy through Carla’s job as a public school teacher in Stafford County, Virginia. But the monthly premium barely covered any of their bills before paying a $2,000 deductible. And by the end of 2016, the Jordans were deep in the hole to doctors, hospitals, an anesthesiologist, urgent care, and various labs and testing centers. Their doctors sent collections notices. Some dropped them as patients until they paid up.

“I actually dreaded going to the mailbox,” Carla recalled. “I feel like I’ve done everything I’m supposed to do.” And yet, she said, sickness pushed the family “right over the brink.”

Since the early 2000s, employers have mostly embraced high-deductible health plans. The thinking has been that requiring workers to shoulder more of the cost of care will also encourage them to cut back on unnecessary spending. But it didn’t work out that way. In the wake of the 2008 financial crisis, many families were hard-pressed to meet their soaring health-insurance deductibles. At the same time, studies show that many put off routine care or skipped medication to save money. That can mean illnesses that might have been caught early can go undiagnosed, becoming potentially life-threatening and enormously costly for the medical system.

Patients Exposed

The share of Americans under 65 enrolled in high deductible plans is rising.

*** Amazon Isn’t the Only Retail Giant Trying to Remake Health ...

How the U.S. insurance system came to stick its customers with increasingly onerous medical bills is a 15-year-long story of miscalculations and missed opportunities. It started in 2003 when President George W. Bush and congressional Republicans passed a change to the tax code that encouraged employers to experiment with high-deductible plans, which ask patients to pay out of pocket for care — sometimes thousands of dollars — before insurance coverage kicks in. The trend got a push when the financial crisis hit: As the economy stalled and employers shed nearly 9 million jobs over three years, companies desperate to slash costs turned to high-deductible plans to save money. The next wave came with the arrival of Obamacare in 2010. Millions who were previously uninsured could now get coverage, but many of them took on deductibles of $1,000 or higher.

The Jordan family never expected to become a casualty of the trend. Little more than a decade ago, they were making more than $100,000 a year. John Jordan had a carpentry business that did well during the housing boom. Carla’s job teaching computer science classes at a local high school gave them steady income and health benefits. When their children, now teenagers, were first born, she recalls paying $500 for her maternity stays in the hospital.

“That was the biggest bill we ever got,” she said.

Since then, Carla’s salary has barely increased and John’s business never recovered after the crash. With student loans, car notes and a house worth less than their mortgage, the Jordans filed for bankruptcy in 2013, allowing them to discharge some debts. But their income never fully bounced back.

They were ill-prepared to deal with sharply escalating health-care bills: Carla’s gallstone, her diabetes diagnoses, John’s seizures, followed by a serious campylobacter infection. The family couldn’t afford the $1,000 it would cost for Carla’s six-week diabetes class. Instead, she got a 40-minute crash course. They shelled out $125 for five pills to treat John’s infection. Still, the bills were piling up. Early in 2017, Carla took a day off from work to go through the stacks of paper, calling each office to negotiate. Few were willing to help.

“It did not really matter to them,” she said. “It was just, ‘When can you pay and how much can you pay?’”

By last year, the couple was making about $79,000, before taxes. They have no savings for retirement or for their children to go to college. “We both live paycheck-to-paycheck,” Carla said. They pay about $35 a month for medications for John’s blood pressure and acid reflux. Carla takes inexpensive metformin—just $3 a month—for diabetes, and doesn’t yet need insulin.

But her diabetes test strips and lancets cost $120 for a three-month supply. To stretch them as long as she can, she checks her blood sugar only when she feels dizzy or nauseous, rather than the standard three times a day. When she had the flu this past winter, she put off going to the doctor until her fever hit 105.

The Jordans’ response to spiraling family medical costs is repeated in families across the country, studies suggest. When one large employer switched all its employees to high-deductible plans, medical spending dropped by 12 percent to 14 percent, according to an analysis by economists at University of California, Berkeley and Harvard. But the workers weren’t learning to shop more effectively for health care. They simply reduced the amount of medical care they used, including preventative care. In high-deductible plans, women are more likely to delay follow-up tests after mammograms, including imaging, biopsies and early-stage diagnoses that could detect tumors when they’re easiest to treat, according to research in the Journal of Clinical Oncology.

“High-deductible plans do reduce health-care costs, but they don’t seem to be doing it in smart ways,” said Neeraj Sood, director of research at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California.

Some big companies are sitting up and taking notice. “We all thought high deductibles are going to drive people to get involved—‘skin in the game,’” Jamie Dimon, the chief executive officer of JPMorgan, said in early June. Instead, “they didn’t get the surgery they needed, when they needed it, because they can’t afford the high deductible in one shot.” JPMorgan is effectively eliminating deductibles for workers making less than $60,000 a year.

Dimon has teamed up with the top executives of Amazon.com Inc. and Berkshire Hathaway Inc. to improve the health care they provide for their workers. The incoming CEO of that venture, surgeon and journalist Atul Gawande, has also noticed the plight of such families as the Jordans. “I had one friend who was bankrupted with a health plan,” Gawande said at the Spotlight Health event in Aspen, Colorado, on Saturday. “He had a $3,000 deductible and couldn’t meet it.”

About five years ago, CVS switched all of its 200,000 employees and their families to health-insurance plans with high deductibles. As the company pushed more costs onto employees, some stopped taking their medications.

“Nobody in their right mind would think that it’s a smart thing to basically be keeping people away from taking their medications,” said Troy Brennan, the chief medical officer at CVS. The company had initially offered a limited selection of generic drugs for free to its workers. But evidence that people were skipping medications prompted CVS to broaden the list, including some brand-name treatments and insulins on the free-drug list, an approach it now recommends to its corporate customers.

The company is also studying a plan to allow employers to offer free, branded drugs to workers in cases where CVS has already negotiated deep discounts. The plan could be in place as soon as 2019.

For the Jordans, such changes are late in coming. On New Year’s Day, 2017, Carla Jordan sat down with her laptop at her kitchen table to write a 20-page letter railing against insurance companies and high medical costs, replete with tables showing their expenses and eight pages of references. She pointed out that health insurance companies’ stock prices, not to mention industry executive salaries, were both soaring, while the thousands of dollars in premiums she paid protected neither her family’s health nor its finances.

“This is an urgent situation, with dire consequences,” she wrote. “Please take action immediately.” She sent the letter to then-President Barack Obama, President-Elect Donald Trump and 220 members of Congress. Only four responded. Seven months later—and for the second time in four years—the couple filed for bankruptcy.

 

601 Charged in $2 Billion in Healthcare Fraud

Department of Justice
Office of Public Affairs

Thursday, June 28, 2018

National Health Care Fraud Takedown Results in Charges Against 601 Individuals Responsible for Over $2 Billion in Fraud Losses

Largest Health Care Fraud Enforcement Action in Department of Justice History Resulted in 76 Doctors Charged and 84 Opioid Cases Involving More Than 13 Million Illegal Dosages of Opioids

Attorney General Jeff Sessions and Department of Health and Human Services (HHS) Secretary Alex M. Azar III, announced today the largest ever health care fraud enforcement action involving 601 charged defendants across 58 federal districts, including 165 doctors, nurses and other licensed medical professionals, for their alleged participation in health care fraud schemes involving more than $2 billion in false billings.  Of those charged, 162 defendants, including 76 doctors, were charged for their roles in prescribing and distributing opioids and other dangerous narcotics.  Thirty state Medicaid Fraud Control Units also participated in today’s arrests.  In addition, HHS announced today that from July 2017 to the present, it has excluded 2,700 individuals from participation in Medicare, Medicaid, and all other Federal health care programs, which includes 587 providers excluded for conduct related to opioid diversion and abuse.

Attorney General Sessions and Secretary Azar were joined in the announcement by Acting Assistant Attorney General John P. Cronan of the Justice Department’s Criminal Division, Deputy Director David L. Bowdich of the FBI, Assistant Administrator John Martin of the Drug Enforcement Administration (DEA), Deputy Inspector General Gary Cantrell of the HHS Office of Inspector General (OIG), Deputy Chief Eric Hylton of IRS Criminal Investigation (CI), Centers for Medicare and Medicaid Services (CMS) Deputy Administrator and Director of the Center for Program Integrity Alec Alexander and Director Dermot F. O’Reilly of the Defense Criminal Investigative Service (DCIS).

Today’s enforcement actions were led and coordinated by the Criminal Division, Fraud Section’s Health Care Fraud Unit in conjunction with its Medicare Fraud Strike Force (MFSF) partners, a partnership between the Criminal Division, U.S. Attorney’s Offices, the FBI and HHS-OIG.  In addition, the operation includes the participation of the DEA, DCIS, IRS-CI, Department of Labor, other various federal law enforcement agencies, and State Medicaid Fraud Control Units.

The charges announced today aggressively target schemes billing Medicare, Medicaid, TRICARE (a health insurance program for members and veterans of the armed forces and their families), and private insurance companies for medically unnecessary prescription drugs and compounded medications that often were never even purchased and/or distributed to beneficiaries.  The charges also involve individuals contributing to the opioid epidemic, with a particular focus on medical professionals involved in the unlawful distribution of opioids and other prescription narcotics, a particular focus for the Department.  According to the CDC, approximately 115 Americans die every day of an opioid-related overdose.

“Health care fraud is a betrayal of vulnerable patients, and often it is theft from the taxpayer,” said Attorney General Sessions.  “In many cases, doctors, nurses, and pharmacists take advantage of people suffering from drug addiction in order to line their pockets. These are despicable crimes. That’s why this Department of Justice has taken historic new steps to go after fraudsters, including hiring more prosecutors and leveraging the power of data analytics. Today the Department of Justice is announcing the largest health care fraud enforcement action in American history.  This is the most fraud, the most defendants, and the most doctors ever charged in a single operation—and we have evidence that our ongoing work has stopped or prevented billions of dollars’ worth of fraud. I want to thank our fabulous partners with the FBI, DEA, our Health Care Fraud task forces, HHS, the Defense Criminal Investigative Service, IRS Criminal Investigation, Medicare, and especially the more than 1,000 federal, state, local, and tribal law enforcement officers from across America who made this possible. By every measure we are more effective at finding and prosecuting medical fraud than ever.”

“Every dollar recovered in this year’s operation represents not just a taxpayer’s hard-earned money—it’s a dollar that can go toward providing healthcare for Americans in need,” said HHS Secretary Azar.  “This year’s Takedown Day is a significant accomplishment for the American people, and every public servant involved should be proud of their work.”

According to court documents, the defendants allegedly participated in schemes to submit claims to Medicare, Medicaid, TRICARE, and private insurance companies for treatments that were medically unnecessary and often never provided.  In many cases, patient recruiters, beneficiaries and other co-conspirators were allegedly paid cash kickbacks in return for supplying beneficiary information to providers, so that the providers could then submit fraudulent bills to Medicare.  Collectively, the doctors, nurses, licensed medical professionals, health care company owners and others charged are accused of submitting a total of over $2 billion in fraudulent billings.  The number of medical professionals charged is particularly significant, because virtually every health care fraud scheme requires a corrupt medical professional to be involved in order for Medicare or Medicaid to pay the fraudulent claims.  Aggressively pursuing corrupt medical professionals not only has a deterrent effect on other medical professionals, but also ensures that their licenses can no longer be used to bilk the system.

“Healthcare fraud touches every corner of the United States and not only costs taxpayers money, but also can have deadly consequences,” said FBI Deputy Director Bowdich.  “Through investigations across the country, we have seen medical professionals putting greed above their patients’ well-being and trusted doctors fanning the flames of the opioid crisis.  I want to thank the agents, analysts and our law enforcement partners in every field office who work each and every day to stop these criminals and hold them accountable for their actions.”

“DEA is committed to ending the opioid crisis occurring in our communities and preventing prescription drug misuse,” said DEA Assistant Administrator Martin.  “DEA will continue to work with our partners every day to protect our citizens while ensuring that patients have adequate access to these critical medications.”

“This year’s operations, focusing on opioid-related schemes, spotlight the far-reaching impact of health care fraud,” said HHS Deputy Inspector General Cantrell.  “Such crimes threaten the vitally important Medicare and Medicaid programs and the beneficiaries they serve.  Though we have made significant progress in our fight against health care fraud; our efforts are not complete.  We will continue to work with our partners to protect the health and safety of millions of Americans.”

“It takes a special kind of person to prey on the sick and vulnerable as happened in many of these health care fraud schemes,” said Deputy Chief Hylton.  “Medical professionals and others callously placed individuals and vital healthcare services in harm’s way simply because of greed.  IRS-CI special agents continue to work side-by-side with other federal, state and local law enforcement officers to uncover these schemes and hold these criminals accountable for their actions.”

“CMS makes it a top priority to protect the health and safety of millions of beneficiaries who depend on vital federal healthcare programs,” said Alec Alexander, deputy administrator and director of the Center for Program Integrity.  “CMS’ Center for Program Integrity collaborates closely with our law enforcement partners to safeguard precious taxpayer dollars. Under Administrator Seema Verma, we will continue to strengthen this partnership with law enforcement in order to ensure the integrity and sustainability of these essential programs that serve millions of Americans.”

“Heath care fraud wounds our service members and veterans alike, as they rely upon and rightfully expect uncompromised care through the Department of Defense’s TRICARE Program,” said DCIS Director O’Reilly.  “Investigations that culminated in enforcement actions over the past several days underscore the steadfast commitment of the Defense Criminal Investigative Service and our investigative partners to vigorously investigate fraud impacting TRICARE.  We remain vigilant in our efforts to ensure the high standards of care our service members, military retirees, and their dependents deserve while safeguarding American taxpayer dollars.”

The Medicare Fraud Strike Force operations are part of a joint initiative between the Department of Justice and HHS to focus their efforts to prevent and deter fraud and enforce current anti-fraud laws around the country.  The Medicare Fraud Strike Force operates in 10 locations nationwide.  Since its inception in March 2007, the Medicare Fraud Strike Force has charged over 3,700 defendants who collectively have falsely billed the Medicare program for over $14 billion.

*********

For the Strike Force locations, in the Southern District of Florida, 124 defendants were charged with offenses relating to their participation in various fraud schemes involving over $337 million in false billings for services including home health care and pharmacy fraud.  In one case, an owner, medical director, and two employees of a sober living facility were charged with conspiracy to commit health care and wire fraud, substantive counts of health care fraud, and substantive counts of money laundering.  The indictment alleges a scheme that illegally recruited patients, paid kickbacks, and defrauded health care benefit programs for widespread fraudulent urine testing.  During the course of the fraudulent scheme, the facility submitted more than $106 million in claims for substance abuse treatment services.

In the Central District of California, 33 defendants were charged for their roles in schemes to defraud insurance programs out of more than $660 million.  For example, one indictment in a compounding pharmacy fraud case alleges an attorney/marketer paid kickbacks and offered incentives such as prostitutes and expensive meals to two podiatrists in exchange for prescriptions written on pre-printed prescription pads, regardless of the medical need for the prescriptions.  Once the prescriptions were filled, members of the conspiracy submitted approximately $250 million in fraudulent claims to federal, state, and private insurers for the compounded drugs.

In the Southern District of Texas, 48 individuals were charged in cases involving more than $291 million in alleged fraud.  Among these defendants are a pharmacy chain owner, managing partner, and lead pharmacist charged with a drug and money laundering conspiracy. According to the indictment, the coconspirators used fraudulent prescriptions to fill bulk orders for over one million pills of hydrocodone and oxycodone, which the pharmacy, in turn, sold to drug couriers for millions of dollars.  In the Northern District of Texas, a home health agency owner was arrested on a criminal complaint for a $2.6 million health care fraud scheme.

In the Eastern District of Michigan, 35 defendants face charges for their alleged roles in fraud, kickback, money laundering and drug diversion schemes involving approximately $197 million in false claims for services that were medically unnecessary or never rendered.  In one case, a physician was charged in separate kickback conspiracies with two home health agency owners, which resulted in more than $12 million in fraudulent insurance billings.

In the Northern District of Illinois, 21 individuals were charged for various fraud schemes involving home health and dental services.  These schemes involved allegedly over $54 million in fraudulent billing.  One case alleges a home health fraud and kickback conspiracy, which resulted in more than $6.2 million paid by Medicare based on the fraudulent billings.

In the Eastern District of New York, 13 individuals were charged with participating in a variety of schemes including kickbacks, services not rendered, identity theft and money laundering involving over $38 million in fraudulent billings.  For example, the owner of a Brooklyn ambulette company was charged in a $7 million conspiracy stemming from the alleged payment of kickbacks for the referral of patients, who subjected themselves to purported physical and occupational therapy and other services, and were transported by the ambulette company.

In the Middle District of Florida, 21 individuals were charged with participating in a variety of schemes involving more than $21 million in fraudulent billings.  In one case, a physician and clinic owner were charged with a conspiracy to defraud Medicare of more than $2.8 million for fraudulent home health billings.

In the Southern Louisiana Strike Force, operating in the Middle and Eastern Districts of Louisiana as well as the Southern District of Mississippi, 42 defendants were charged in connection with health care fraud, drug diversion, and money laundering schemes involving more than $16 million in fraudulent billings.  One case alleges that three pharmacy owners and a nurse practitioner conspired to unlawfully dispense controlled substances and defraud TRICARE and private insurance companies out of $12 million.

In the Corporate Strike Force, five defendants were charged in the Middle District of Tennessee with a kickback conspiracy at a durable medical equipment company, which allegedly resulted in more than $1 million in kickbacks and over $2.5 million in fraudulent billings to Medicare.

 *********

In addition to the Strike Force locations, today’s enforcement actions include cases and investigations brought by an additional 46 U.S. Attorney’s Offices, including the execution of  search warrants in various investigations conducted by the Central and Northern Districts of California, Middle District of Florida, Southern District of Georgia, Western District of Kentucky, Eastern District of Michigan, Western District of North Carolina, Eastern and Western Districts of Texas, Eastern and Western Districts of Virginia, and Western District of Washington.

In the Northern and Southern Districts of Alabama, 15 defendants were charged for their roles in eight health care fraud schemes involving compounding pharmacy fraud and unlawful distribution of controlled substances.

In the Eastern District of California, four defendants were charged for their roles in two health care fraud schemes, one of which included forged prescriptions.

In the Southern District of California, seven defendants, including a physician, were charged for their roles in three health care fraud schemes and one scheme involving identity theft and services that were not rendered.

In the District of Colorado, a defendant was charged with health care fraud related to billings to Medicaid and Medicare.

In the District of Connecticut, three defendants, including two medical professionals, were charged for their roles in two schemes involving compounding drugs and unlawful distribution of Schedule II and IV controlled substances.

In the District of Delaware, a physician/owner of a pain management clinic was charged with unlawfully prescribing more than two million dosage units of Oxycodone products.

In the District of Columbia, a durable medical equipment company owner was charged with defrauding Medicaid of $9.8 million.

In the Northern District of Florida, four defendants were charged in a scheme to defraud TRICARE and other private insurance companies out of over $8 million for medically unnecessary compounded creams and pills.

In the Northern, Middle, and Southern Districts of Georgia, 12 defendants, including two physicians, were charged in nine health care fraud, drug diversion, or compounding pharmacy schemes involving over $13.5 million in fraudulent billings.

In the District of Idaho, three defendants, all of who are medical professionals, were charged for their roles in three separate fraud schemes involving controlled substances.

In the Central and Southern Districts of Illinois, seven defendants were charged in six separate schemes to defraud the Medicaid program.

In the Northern District of Indiana, eight defendants were charged in various health care fraud schemes to defraud both the Medicare and Medicaid programs.

In the Northern District of Iowa, two defendants – both medical professionals – were charged for their roles in two opioid-related schemes.

In the Districts of Kansas and the Northern and Western Districts of Oklahoma, 12 defendants, including four physicians, were charged in various unlawful distribution of controlled substances schemes.  In the Western District of Oklahoma, one case marks the district’s first time charging unlawful distribution of controlled substances resulting in a death.

In the Eastern and Western Districts of Kentucky, 12 defendants, including five medical professionals, were charged in various schemes involving health care fraud, unlawful distribution of controlled substances, aggravated identity theft, and money laundering.  One case involved the operation of two false-front medical clinics.

In the Districts of Maine and Vermont, two defendants were charged for their roles in two schemes to defraud various government programs including Medicare, Medicaid, and ones run by the HHS’ Administration for Children and Families.

In the District of Nebraska, seven defendants, including one physician, were charged in five separate schemes to defraud Medicare, Medicaid, and various HHS programs.

In the District of Nevada, four defendants, including three medical professionals were charged with conspiracies to commit health care fraud and distribute controlled substances.

In the District of New Jersey, eight defendants, including a New York doctor, an anesthesiology technologist for a Philadelphia hospital, and the owner of a medical billing company, were charged for their roles in five schemes to defraud private insurance companies of over $16 million.

In the Southern District of New York, two defendants were charged in schemes involving health care fraud or drug diversion.

In the Middle District of North Carolina, two defendants were charged with a conspiracy to defraud Medicare out of over $4 million.

In the Southern District of Ohio, three defendants – all medical professionals – were charged for their roles in two health care fraud schemes, one of which involved illegal drug distribution and kickbacks.

In the Eastern and Middle Districts of Pennsylvania, 12 defendants were charged for their roles in three drug diversion schemes.

In the Western District of Pennsylvania, four defendants – all physicians – were charged in various health care fraud and drug diversion schemes. One scheme involved 32,000 dosage units of buprenorphine.

In the District of Rhode Island, one defendant was charged for participating in a theft and aggravated identity theft scheme.

In the District of South Carolina, three defendants were charged for their separate roles in a conspiracy to possess with the intent to distribute fentanyl.

In the District of South Dakota, two defendants were charged in separate cases, one of which involved a scheme to defraud the Indian Health Service.

In the Middle District of Tennessee, 10 defendants were charged in two separate schemes, including a conspiracy to fraudulently obtain oxycodone.

In the Eastern District of Texas, two defendants were charged for their role in health care fraud schemes to defraud the Medicare and Medicaid programs.

In the District of Utah, two defendants were charged in two cases, one of which involved a $31 million scheme to defraud Medicare and Medicaid.

In the Western District of Virginia, eight defendants were charged for their alleged roles in health care fraud schemes.  One $45 million scheme to defraud Medicaid involved falsification of documents in patient files.

In the Eastern District of Washington, a dentist and another individual were indicted for distributing and conspiring to distribute hydrocodone and tramadol without a legitimate medical purpose.

In the Eastern District of Wisconsin, three defendants were charged in a scheme involving the unlawful distribution of controlled substances and aggravated identity theft.

In addition, in the states of Arizona, Arkansas, California, Connecticut, Delaware, Florida, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maine, Michigan, Missouri, Mississippi, Nevada, New York, Oklahoma, Pennsylvania, Texas, Vermont, and Washington, 97 defendants have been charged with defrauding the Medicaid program out of over $27 million.  These cases were investigated by each state’s respective Medicaid Fraud Control Units.  In addition, the Medicaid Fraud Control Units of the states of California, District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Nevada, North Carolina, Ohio, Texas, Tennessee, and Virginia participated in the investigation of many of the federal cases discussed above.

The cases announced today are being prosecuted and investigated by U.S. Attorney’s Offices nationwide, along with Medicare Fraud Strike Force teams from the Criminal Division’s Fraud Section and from the U.S. Attorney’s Offices in the Southern District of Florida, Eastern District of Michigan, Eastern District of New York, Southern District of Texas, Central District of California, Eastern District of Louisiana, Northern District of Texas, Northern District of Illinois, Middle District of Louisiana, and the Middle District of Florida; and agents from the FBI, HHS-OIG, DEA, DCIS, IRS-CI, Department of Labor, other various federal law enforcement agencies, and state Medicaid Fraud Control Units.

A complaint, information, or indictment is merely an allegation, and all defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

Additional documents related to this announcement will shortly be available here:

https://www.justice.gov/opa/documents-and-resources-june-28-2018.

This operation also highlights the great work being done by the Department of Justice’s Civil Division.  In the past fiscal year, the Department of Justice, including the Civil Division, has collectively won or negotiated over $2 billion in judgements and settlements related to matters alleging health care fraud.